Dear AAPS members–
For weeks now I have been getting more and more excited for our Land O' Lakes summer meetings. I am looking forward to the in-depth conversations of these smaller, intimate gatherings-they have a really sharp focus on specific innovations, technology, and analysis approaches, and on the regulatory frameworks that guide and mold all of it!
As I build my schedule for the Land O' Lakes Bioanalytical Conference taking place next week, I once again realize how all of our work has to begin and end with the patient. If anything, our response to COVID-19 has brought to the forefront the value of patient-centric approaches, from sampling to drug delivery and effectiveness. This is clearly visible in the great program that @Chad Briscoe and the conference's Scientific Programming Committee have assembled. I am looking forward to learning more about how patient-centric sampling approaches are transforming clinical development paradigms, for example.
For those of us who have a lot of experience with running laboratories, it will be fascinating to hear case studies on the impact the pandemic has had on day-to-day lab operations. From coping with the extraordinary amounts of samples, to adapting to remote audits, some operational workflows have been dramatically impacted-and not few of them perhaps for the indefinite future.
I have several topic threads that I am following across the year during our Four Seasons of Science at AAPS. This year I am diving deeper into immunogenicity assessment, qPCR, and of course advances in mass spectrometry methodology. (Those of you who know me are not surprised!) The July Land O' Lakes Conference is always particularly rich in mass spec innovation, and this year is no different-with a great set of presentations about technique and technology innovations for difficult analytical matrices.
Just like at last year's conference, we have coffee chats at the start of each meeting day. I hope you will join me and the bioanalytical gang in these informal, fun exchanges-they always prepare me for the day's program.
The conference will close with a look at regulatory learnings for a post-pandemic world. The handling of the pandemic will have ripples that I hope reshape the regulatory shore to allow quicker introduction of new technologies and approaches into a regulated environment, reaping benefits for faster patient access to medicines across the modality and indication spectrum.
With so much bioanalytical excitement next week, it is easy to get distracted from a couple of important deadlines that are coming up in July as well. @Dale Eric Wurster is counting on you to cast your votes in the AAPS election by July 20. Do not miss this opportunity to shape and support AAPS governance by assuring a strong Board of Directors for our organization!
If you would like to present your research at PharmSci 360 this October (We hope you will!), be aware that the late-breaking poster abstract deadline is days away on July 21!
The program for PharmSci 360 is now online-or at least, the program so far! Later this summer we will release the agenda for the in-person conference in Philadelphia. What you can see right now is the fantastic lineup of sessions that will become available online just before we head to Pennsylvania. I hope the meeting is already firmly on your calendar for October 17-20 and you are registered. The early registration deadline is August 10, so don't delay!
There is no slowing our science at AAPS, even when the summer days are long and hot! I hope you let our science inspire you to look up and ahead.
Tina
Share your thoughts with Tina via the AAPS Community!